| abstract |
The present invention relates to at least partially novelly substituted tetracycline compounds. Such tetracycline compounds have a number of tetracycline compound-reactive states, such as bacterial infections and neoplastic therapies, and other known applications for tetracycline compounds, such as tetracycline efflux blocking and gene expression control. Can be used forn n n Tetracycline Compounds, Tetracycline Compound-Reactive States |